임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
51건 표시
- 3상모집 중단 (진행 중)· Hidradenitis SuppurativaA Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
리드: 노바티스
- 3상모집 중단 (진행 중)· Relapsing Multiple Sclerosis (RMS)Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
리드: 노바티스
- 3상모집 중단 (진행 중)· Hidradenitis SuppurativaA Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
리드: 노바티스
- 3상모집 중단 (진행 중)· Polymyalgia RheumaticaOpen-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
리드: 노바티스
- 3상모집 중단 (진행 중)· Chronic Inducible UrticariaA Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines
리드: 노바티스
- 3상모집 중단 (진행 중)· Follicular Lymphoma (FL)A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
리드: 노바티스
- 3상모집 중단 (진행 중)· Hyperlipoproteinemia (a)An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
리드: 노바티스
- 3상모집 중단 (진행 중)· Systemic Lupus ErythematosusPhase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
리드: 노바티스
- 3상모집 중단 (진행 중)· Primary Prevention of Atherosclerotic Cardiovascular DiseaseA Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
리드: 노바티스
- 3상모집 중단 (진행 중)· Systemic Lupus ErythematosusPhase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
리드: 노바티스
- 3상모집 중단 (진행 중)· Primary Immune Thrombocytopenia (ITP)Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
리드: 노바티스
- 3상모집 중단 (진행 중)· Primary Immune ThrombocytopeniaA Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
리드: 노바티스
- 3상모집 중단 (진행 중)· Warm Autoimmune Hemolytic Anemia (wAIHA)A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia
리드: 노바티스
- 3상모집 중단 (진행 중)· Spinal Muscular Atrophy (SMA)Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
리드: 노바티스
- 3상모집 중단 (진행 중)· Chronic Spontaneous UrticariaAn Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib
리드: 노바티스
- 3상모집 중단 (진행 중)· Philadelphia Chromosome-Positive Chronic Myeloid LeukemiaA Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)
리드: 노바티스
- 3상모집 중단 (진행 중)· Sjogren SyndromeThree-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
리드: 노바티스
- 3상모집 중단 (진행 중)· Lupus NephritisSafety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
리드: 노바티스
- 3상모집 중단 (진행 중)· Coronary Artery DiseaseCoronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
리드: 노바티스
- 3상모집 중단 (진행 중)· Non-Small Cell Lung CancerStudy of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
리드: 노바티스
- 3상모집 중단 (진행 중)· Relapsing Multiple SclerosisEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
리드: 노바티스
- 3상모집 중단 (진행 중)· Relapsing Multiple SclerosisEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
리드: 노바티스
- 3상모집 중단 (진행 중)· Atherosclerotic Cardiovascular DiseaseStudy of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
리드: 노바티스
- 3상모집 중단 (진행 중)· Differentiated Thyroid Cancer (DTC)Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer
리드: 노바티스
- 3상모집 중단 (진행 중)· Chronic Myeloid Leukemia (CML) Philadelphia Chromosome PositiveA Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
리드: 노바티스
- 3상모집 중단 (진행 중)· Multiple Sclerosis (MS)Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
리드: 노바티스
- 3상모집 중단 (진행 중)· Primary IgA NephropathyA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
리드: 노바티스
- 3상모집 중단 (진행 중)· Advanced Breast CancerTrastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
협력: 노바티스
- 3상모집 중단 (진행 중)· Paroxysmal Nocturnal HemoglobinuriaLong-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
리드: 노바티스
- 3상모집 중단 (진행 중)· Prostatic Neoplasms177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
리드: 노바티스
- 3상모집 중단 (진행 중)· MyelofibrosisPhase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
리드: 노바티스
- 3상모집 중단 (진행 중)· Advanced HER2+Breast CancerStudy of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation
리드: 노바티스
- 3상모집 중단 (진행 중)· Hidradenitis SuppurativaExtension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
리드: 노바티스
- 3상모집 중단 (진행 중)· Spinal Muscular Atrophy Type ILong-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
리드: 노바티스
- 3상모집 중단 (진행 중)· Cardiovascular Disease and Lipoprotein(a)Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD
리드: 노바티스
- 3상모집 중단 (진행 중)· Sickle Cell Disease (SCD)Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
리드: 노바티스
- 3상모집 중단 (진행 중)· MigraineEfficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
리드: 암젠 · 협력: 노바티스
- 3상모집 중단 (진행 중)· Breast Cancer FemaleAdj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC
협력: 노바티스
- 3상모집 중단 (진행 중)· Relapsing Multiple SclerosisLong-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
리드: 노바티스
- 3상모집 중단 (진행 중)· Early Breast CancerA Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
리드: 노바티스
- 3상모집 중단 (진행 중)· Atherosclerotic Cardiovascular DiseaseA Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
협력: 노바티스
- 3상모집 중단 (진행 중)· Multiple SclerosisSafety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
리드: 노바티스
- 3상모집 중단 (진행 중)· SarcomaCombined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma
협력: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.